Long-term survival of kidneys transplanted from live A2 donors to O and B recipients

American Journal of Transplantation

Volumn 7, Issue 5, 2007, Pages 1181-1184

  Bryan, C F ^a   Nelson, P W ^b   Shield, C F ^c   Warady, B A ^d   Winklhofer, F T ^e   Murillo, D ^f   Wakefield, M R ^g  

^a Midwest Transplant Network   (United States)

^b Department of Surgery   (United States)

^c Via Christi Rehabilitation Center   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e UNIVERSITY OF KANSAS HOSPITAL   (United States)

^f Research Medical Center Brookside Campus   (United States)

^g University Hospital   (United States)

Author keywords

Access to transplantation; Clinical kidney transplantation; Donor recipient matching; Live donor transplantation; Long term graft function; Organ utilization

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ARTICLE; BLOOD GROUP A; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; BLOOD GROUP O; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECIPIENT; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; AZATHIOPRINE; BLOOD GROUPING AND CROSSMATCHING; CYCLOSPORINE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247384282     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01750.x     Document Type: Article

References (12)

1. Sorensen JB, Grant WJ, Belnap LP, Stinson J, Fuller TC. Transplantation of ABO group A2 kidneys from living donors into group O and B recipients. Am J Transplant 2001 1 : 296 299.
2. Bryan CF, Cherikh WS, Maghirang J et al. National experience with live donor renal transplantation of A2/A2B into B and O patients [abstract]. Am J Transplant, 2004 4 : 414.
3. Alkhunaizi AM, De Mattos AM, Barry JM, Bennett WM, Norman DJ. Renal transplantation across the ABO barrier using A2 kidneys. Transplantation 1999 67 : 1319 1324.
4. Breimer ME, Molne J, Norden G, Rydberg L, Thiel G, Svalander CT. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and Secretor status. Transplantation 2006 82 : 479 485.
5. Bryan CF, Winklhofer FT, Murillo D, Ross G, Nelson PW, Shield CF, Warady BA. Improving access to kidneys transplantation without decreasing graft survival: Long-term outcomes of blood group A2/A2B deceased donor kidneys in B recipients. Transplantation 2005 80 : 75 80.
6. Nelson PW, Helling TS, Shield CF, Beck M, Bryan CF. Current experience with renal transplantation across the ABO barrier. Am J Surgery 1992 164 : 541 545.
7. Shimmura H, Tanabe K, Ishida H et al. Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression. Transplantation 2005 80 : 985 988.
8. Bryan CF, Nelson PW, Shield CF et al. Transplantation of A2 and A2B kidneys from deceased donors into B waiting list candidates increases their transplantation rate. In : Cecka JM, Terasaki PI eds). Clinical Transplants 2004, Los Angeles, CA, UCLA Immunogenetics Center, 2005 : 127 133.
9. Haji NI, Nelson RE, Jones MNA et al. Will transplantation of kidneys from donors with blood group A2 into recipients with blood group B help British Indo-Asian patients with renal failure? Transplantation 2004 2004 : 77 630.
10. Williams WW, Cherikh W, Young C, Fan PY, Bryan CF. Updated report on the OPTN/UNOS national voluntary variance to allocate A2/A2B deceased donor kidneys to blood group B candidates [abstract]. American Journal of Transplantation/ Transplantation 2006 WTC Supplement LB-10 : 1058.
11. Bryan CF, Cherikh WS, Cheng Y et al. ABO blood group influences a candidate's likelihood of receiving an HLA zero antigen mismatch kidney. Clin Transplant 2004 18 : 55 60.
12. Bryan CF, Polesky H, Eisenbrey AB et al. Implications of ABO error rates in proficiency testing for solid organ transplantation. Transplantation 2006 82 : 733 736.